Stress during pregnancy, perhaps around the 6-to-8-month mark especially, may prime certain immune cells in a fetus’s skin to overreact, leading to eczema. Immune cells called mast cells in the skin ...

Allergies are becoming more common in the United States. According to the Centers for Disease Control and Prevention's National Center for Health Statistics, nearly 1 in 3 adults and over 1 in 4 ...

Allergies are becoming more common in the United States. According to the Centers for Disease Control and Prevention’s National Center for Health Statistics, nearly 1 in 3 adults and over 1 in 4 ...

Alyce Collins is a Newsweek Life and Trends reporter based in Birmingham, U.K. with a focus on trending topics that are both engaging and relatable. Since 2019, she has covered a variety of ...

A phase 3 trial of Sanofi’s eczema prospect amlitelimab has hit its primary and key secondary endpoints. Yet, with the data falling short of analyst expectations, shares in the company opened down 9% ...

Scientists show that prenatal stress reshapes fetal mast cells and sensory neurons, creating a fragile skin barrier that sparks early-life eczema in mice. Study: Maternal stress triggers early-life ...

July 24, 2025 – The FDA has approved a new treatment as the first and only skin cream for a specific type of hand eczema that affects about 1 in every 10 people globally. The cream, sold under the ...

Claire Meitinger was told to "use a topical steroid cream on the dark spot" because it was likely just eczema, despite it not being dry, itchy, or flaky. ‘Just Hang Up’: FBI Warns of New Scam Toddler ...

Investing.com -- Sanofi ’s experimental drug amlitelimab successfully met all primary endpoints in a Phase 3 clinical trial involving adolescent and adult patients with eczema, also known as atopic ...

LONDON (Reuters) -Shares in French drugmaker Sanofi fell more than 10% on Thursday, wiping nearly $13 billion off its market value, after late-stage trial data for its experimental inflammatory ...